MED

Value 202020212022202320242025 Current Total common shares outstanding 11.77 M11.54 M10.84 M10.9 M10.94 M10.99 M 11.12 M Enterprise value 2.15 B2.31 B1.16 B670.76 M101.8 M28.08 M 47.28 M Price to earnings ratio 22.6215.089.047.7292.74-6.28 -5.87 Price to sales ratio 2.491.620.810.720.320.3 0.34 Price to cash flow ratio 16.0226.176.675.197.8917.09 31.46 Price to book ratio 14.812.228.373.810.920.59 0.14 Enterprise value to EBITDA ratio 15.6210.586.145.0213.42-9.69 -16.59 Return on assets % 0.370.410.450.320.01-0.08 -0.01 Return on equity % 0.650.810.930.490.01-0.09 -0.01 Return on invested capital % 922.67768.17578.73407.817.51-293.29 -27.65 Gross margin % 74.6573.8971.3472.3773.871.33 68.06 Operating margin % 14.3514.1711.5611.790.48-3.68 -4.33 EBITDA margin % 14.7114.3211.8312.471.26-0.75 0.16 Net margin % 1110.758.989.270.35-4.84 -2.79 Quick ratio 1.620.750.741.842.684.22 4.3 Current ratio 2.11.811.582.433.344.69 4.8 Inventory turnover —————— — Asset turnover 3.974.534.473.422.031.56 0.3 Debt to assets ratio —————— — Debt to equity ratio —————— — Long term debt to total assets ratio —————— — Long term debt to total equity ratio —————— — Operating cash flow per share 12.25817.2613.522.230.62 0.34 EBIT per share 11.0317.9316.1811.26-0.45-1.81 -1.57 EBITDA per share 11.6118.516.7712.250.69-0.26 -0.08 Total debt per share —————— — Cash per share 14.729.277.7813.6615.1115.15 15.3 Net current asset value per share 19.7725.9819.7620.5119.5618.37 18.41 Tangible book value per share 13.2717.1413.7518.4519.1718.11 17.96 Working capital per share 10.3811.67.2612.0613.714.45 14.58 Book value per share 13.2717.1413.7518.4519.1718.11 17.96